nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AQP1—salivary gland cancer	0.095	0.095	CbGpPWpGaD
Tolvaptan—AVPR2—Aquaporin-mediated transport—AQP1—salivary gland cancer	0.0829	0.0829	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—MC3R—salivary gland cancer	0.0709	0.0709	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—MC3R—salivary gland cancer	0.0704	0.0704	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0466	0.0466	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.0355	0.0355	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—MC3R—salivary gland cancer	0.0334	0.0334	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—MC3R—salivary gland cancer	0.0331	0.0331	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.0302	0.0302	CbGpPWpGaD
Tolvaptan—AVPR2—Arf6 trafficking events—CDH1—salivary gland cancer	0.027	0.027	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0261	0.0261	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0259	0.0259	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0249	0.0249	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0224	0.0224	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0222	0.0222	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—MC3R—salivary gland cancer	0.017	0.017	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—MC3R—salivary gland cancer	0.0169	0.0169	CbGpPWpGaD
Tolvaptan—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0152	0.0152	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0114	0.0114	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.0109	0.0109	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00983	0.00983	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00976	0.00976	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00963	0.00963	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—MC3R—salivary gland cancer	0.00956	0.00956	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00938	0.00938	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00908	0.00908	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MC3R—salivary gland cancer	0.00874	0.00874	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MC3R—salivary gland cancer	0.00868	0.00868	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00827	0.00827	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—WNT5B—salivary gland cancer	0.00656	0.00656	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—WNT5B—salivary gland cancer	0.00651	0.00651	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL17RD—salivary gland cancer	0.00634	0.00634	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL17RD—salivary gland cancer	0.00629	0.00629	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAML3—salivary gland cancer	0.00579	0.00579	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAML3—salivary gland cancer	0.00575	0.00575	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MC3R—salivary gland cancer	0.00516	0.00516	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MC3R—salivary gland cancer	0.00513	0.00513	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00497	0.00497	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00494	0.00494	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00475	0.00475	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00457	0.00457	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DTX4—salivary gland cancer	0.00451	0.00451	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DTX4—salivary gland cancer	0.00448	0.00448	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.00409	0.00409	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00395	0.00395	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.00379	0.00379	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF16—salivary gland cancer	0.00373	0.00373	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF16—salivary gland cancer	0.00371	0.00371	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00361	0.00361	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00352	0.00352	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAML2—salivary gland cancer	0.00324	0.00324	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAML2—salivary gland cancer	0.00322	0.00322	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00314	0.00314	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00288	0.00288	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAG1—salivary gland cancer	0.00277	0.00277	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGFR4—salivary gland cancer	0.00276	0.00276	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAG1—salivary gland cancer	0.00275	0.00275	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGFR4—salivary gland cancer	0.00274	0.00274	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FBXW7—salivary gland cancer	0.00271	0.00271	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FBXW7—salivary gland cancer	0.00269	0.00269	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00269	0.00269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FOXO3—salivary gland cancer	0.00229	0.00229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FOXO3—salivary gland cancer	0.00227	0.00227	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00218	0.00218	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00194	0.00194	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00189	0.00189	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAP2K2—salivary gland cancer	0.00186	0.00186	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00173	0.00173	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00169	0.00169	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.00154	0.00154	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—salivary gland cancer	0.00152	0.00152	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PYGB—salivary gland cancer	0.00143	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREBBP—salivary gland cancer	0.00139	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREBBP—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00125	0.00125	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.00117	0.00117	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00115	0.00115	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.00112	0.00112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—salivary gland cancer	0.00109	0.00109	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AQP1—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—salivary gland cancer	0.000991	0.000991	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—salivary gland cancer	0.000984	0.000984	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.00095	0.00095	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EP300—salivary gland cancer	0.000945	0.000945	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EP300—salivary gland cancer	0.000939	0.000939	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000883	0.000883	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000851	0.000851	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000823	0.000823	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NUP62—salivary gland cancer	0.00081	0.00081	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000803	0.000803	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.00072	0.00072	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000699	0.000699	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000694	0.000694	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000693	0.000693	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—salivary gland cancer	0.000677	0.000677	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—salivary gland cancer	0.000672	0.000672	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00067	0.00067	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—salivary gland cancer	0.000647	0.000647	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—salivary gland cancer	0.000642	0.000642	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000629	0.000629	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000499	0.000499	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000495	0.000495	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.000314	0.000314	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—salivary gland cancer	0.000224	0.000224	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EP300—salivary gland cancer	0.000214	0.000214	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CREBBP—salivary gland cancer	0.000193	0.000193	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—salivary gland cancer	0.000138	0.000138	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EP300—salivary gland cancer	0.000132	0.000132	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	9.75e-05	9.75e-05	CbGpPWpGaD
